Finzati - Logo
MBIO logo

Mustang Bio, Inc.

MBIOBiotechnology
$0.54
-0.02 (-3.05%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.35M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 2.22Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.54
Change-3.05%
Market Cap$4.35M
52W Range0.53 - 1.85
Beta2.05
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio2.22
Quick Ratio2.22
Volume9.39K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0Healthy liquidity · 2.22Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/22/2017
Industry: Biotechnology
P/B i: 0.51
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 2.22
Quick Ratio: 2.22
Status: Good

Insider Transactions

Recent executive and insider activity

Litchman Manuel MD
Transaction: 04/24/2026
SELL
Change
-19
Price
$0.75
Filing
04/27/2026
Type
SELL
Fortress Biotech, Inc.
Transaction: 01/02/2026
BUY
Change
+278,385
Price
Not reported
Filing
01/05/2026
Type
BUY
Jin David
Transaction: 12/30/2025
BUY
Change
+247
Price
$0.96
Filing
12/30/2025
Type
BUY